Related Experiment Videos
Piribedil could modify dopamine turnover in cochleas under noise stimulation
M A Vicente-Torres1, P Gil-Loyzaga, P Fernández
1Departamento de Ciencias Morfológicas, Facultad de Medicina, Universidad Complutense, Madrid, España.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties
|November 1, 1993
Summary
Noise exposure depletes cochlear dopamine (DA) levels in untreated animals. Pretreatment with piribedil, a D2 agonist, significantly preserved cochlear DA content, suggesting it modifies DA turnover during noise stimulation.
Area of Science:
- Neuroscience
- Auditory Science
- Pharmacology
Background:
- Dopamine (DA) is a neurotransmitter potentially involved in the lateral efferent olivocochlear pathway.
- Noise-induced hearing loss is a significant sensory deficit.
- Understanding the role of neurotransmitters in cochlear response to noise is crucial.
Purpose of the Study:
- To investigate the effect of noise exposure on cochlear dopamine levels.
- To determine if piribedil, a D2 agonist, can mitigate noise-induced changes in cochlear dopamine.
Main Methods:
- Analysis of cochlear dopamine content using high-performance liquid chromatography with electrochemical detection.
- Experimental groups included exposure to varying intensities of white noise (70, 90, 110 dB SPL) or silence.
- Animals were either pretreated with piribedil or served as untreated controls.
Main Results:
- Control animals showed a progressive decrease in cochlear DA concentration following noise exposure.
- Piribedil pretreatment significantly reduced the decrease in cochlear DA levels observed in noise-exposed animals.
- Noise stimulation altered cochlear DA turnover, an effect modulated by piribedil.
Conclusions:
- Noise exposure significantly impacts cochlear dopamine levels.
- Piribedil, a D2 agonist, appears to protect against noise-induced depletion of cochlear dopamine.
- These findings suggest piribedil influences cochlear dopamine turnover in response to acoustic trauma.